Statistiken für The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression
Aufrufe insgesamt
| views | |
|---|---|
| The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression | 2 |
Aufrufe pro Monat
| views | |
|---|---|
| November 2023 | 0 |
| Dezember 2023 | 0 |
| Januar 2024 | 0 |
| Februar 2024 | 2 |
| März 2024 | 0 |
| April 2024 | 0 |
| Mai 2024 | 0 |
Datei-Aufrufe
| views | |
|---|---|
| 10.1111_1440-1681.13452.pdf | 5 |
Top-Länder-Aufrufe
| views | |
|---|---|
| Deutschland | 1 |
| Indonesien | 1 |
Top-Städte-Aufrufe
| views | |
|---|---|
| Jakarta | 1 |